AssetMark Inc
CHE icon

AssetMark Inc’s Chemed CHE Stock Holding History

AssetMark Inc’s Portfolio CHE Stock Details CHE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$29.3K Buy
58
+30
+107% +$15.5K ﹤0.01% 2101
2026
Q2 		$13K Buy
28
+15
+115% +$6.31K ﹤0.01% 2356
2026
Q1 		$4.91K Sell
13
-8
-38% -$3.43K ﹤0.01% 2575
2025
Q4 		$8.98K Buy
21
+13
+163% +$5.66K ﹤0.01% 2245
2025
Q3 		$3.58K Sell
8
-15
-65% -$6.79K ﹤0.01% 2443
2025
Q2 		$11.2K Buy
23
+5
+28% +$2.85K ﹤0.01% 1933
2025
Q1 		$11.1K Buy
18
+4
+29% +$2.27K ﹤0.01% 1830
2024
Q4 		$7.42K Sell
14
-1
-7% -$564 ﹤0.01% 1850
2024
Q3 		$9.02K Buy
+15
New +$8.5K ﹤0.01% 1640
2022
Q1 		– Sell
-2
Closed -$1K – 1563
2021
Q4 		$1K Hold
2
– – ﹤0.01% 1417
2021
Q3 		$1K Buy
+2
New +$943 ﹤0.01% 1309
2021
Q2 		– Sell
-2
Closed -$1K – 1343
2021
Q1 		$1K Buy
+2
New +$980 ﹤0.01% 1224
2020
Q2 		– Sell
-43
Closed -$19K – 1280
2020
Q1 		$19K Sell
43
-8,371
-99% -$3.74M ﹤0.01% 878
2019
Q4 		$3.7M Buy
8,414
+8,371
+19,467% +$3.52M 0.03% 272
2019
Q3 		$18K Hold
43
– – ﹤0.01% 896
2019
Q2 		$16K Hold
43
– – ﹤0.01% 913
2019
Q1 		$14K Sell
43
-8
-16% -$2.46K ﹤0.01% 939
2018
Q4 		$14K Hold
51
– – ﹤0.01% 946
2018
Q3 		$16K Hold
51
– – ﹤0.01% 968
2018
Q2 		$16K Hold
51
– – ﹤0.01% 970
2018
Q1 		$14K Sell
51
-190
-79% -$50.3K ﹤0.01% 986
2017
Q4 		$59K Sell
241
-2,196
-90% -$499K ﹤0.01% 738
2017
Q3 		$492K Buy
2,437
+2,406
+7,761% +$473K 0.01% 356
2017
Q2 		$6K Sell
31
-18
-37% -$3.58K ﹤0.01% 1080
2017
Q1 		$9K Sell
49
-3
-6% -$523 ﹤0.01% 986
2016
Q4 		$8K Buy
52
+1
+2% +$147 ﹤0.01% 998
2016
Q3 		$7K Buy
+51
New +$7.1K ﹤0.01% 1009

Other funds holding CHE

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Boston Trust Walden
Boston Trust Walden Boston, Massachusetts $12.4B AUM 21.62% 1-Year Est. Return
Copeland Capital Management
Copeland Capital Management Conshohocken, Pennsylvania $4.34B AUM 17.52% 1-Year Est. Return
Van Berkom & Associates
Van Berkom & Associates Montreal, Quebec, Canada $2.81B AUM 6.02% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $64.1B AUM 28.9% 1-Year Est. Return
ProShare Advisors
ProShare Advisors Bethesda, Maryland $69.5B AUM 31.38% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 33.83% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

AssetMark Inc's CHE Position: Q3 2026 in Review

AssetMark Inc increased its Chemed (CHE) stake by 107% in Q3 2026, buying an estimated $15.5K and bringing the position to 58 shares worth $29.3K. The position accounts for ﹤0.01% of the portfolio, ranked #2101.

AssetMark Inc first reported a position in CHE in Q3 2016 and has held it in 27 quarters since. The position peaked at $3.7M in Q4 2019. 243 funds tracked by Wall St. Rank hold CHE as of Q3 2026.

  • AssetMark Inc held 58 shares of Chemed worth $29.3K as of Q3 2026.
  • AssetMark Inc bought 30 Chemed shares in Q3 2026, an estimated $15.5K.
  • Chemed made up ﹤0.01% of AssetMark Inc's portfolio in Q3 2026, its #2101 holding.
  • AssetMark Inc first reported a position in Chemed in Q3 2016 and has held it in 27 quarters since.
  • AssetMark Inc's Chemed position peaked at $3.7M in Q4 2019.
  • 243 funds tracked by Wall St. Rank held Chemed as of Q3 2026.

Based on AssetMark Inc's 13F filing for Q3 2026, filed 21 Oct 2026.